PubMedCrossRef 6. Plante M, Renaud MC, Têtu B, Harel F, Roy M: Laparoscopic sentinel node mapping in early-stage cervical cancer. Gynecol Oncol 2003,91(3):494–503.PubMedCrossRef 7. Stehman FB, Bundy BN, DiSaia PJ, Keys HM, Larson JE, Fowler WC: Carcinoma of the cervix treated with radiation therapy. A multi-variate analysis of prognostic variables in the Gynecologic

oncology group. Cancer 1991, 67:2776–85. PubMedCrossRef 8. Holmgren L, O’Reilly MS, Folkman J: Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995,1(2):149–53.PubMedCrossRef 9. Häfner N, Gajda M, Altgassen C, Hertel H, Greinke C, Hillemanns P, Schneider A, Dürst M: HPV16-E6 mRNA is superior to cytokeratin 19 mRNA as a molecular marker for the detection of disseminated tumour cells in sentinel lymph nodes of patients with cervical cancer Eltanexor by quantitative reverse-transcription PD0332991 mw PCR. Int J Cancer 2007,120(9):1842–6.PubMedCrossRef 10. Dargent D, Enria R: Laparoscopic assessment of the sentinel lymph nodes in early cervical cancer. Technique–preliminary results and future developments. Crit Rev Oncol Hematol 2003,48(3):305–310.PubMedCrossRef

11. Schwartz GF, Giuliano AE, Veronesi U: Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast April 19 to 22,2001. Philadelphia, Pennsylvania. Hum Pathol 2002, 33:579–89.PubMedCrossRef 12. Machiolé P, Buénerd A, Benchaib M, Nezhat K, Dargent D, Mathevet P: Clinical significiance of lympho vascular space involvement and lymph node micrometastases in early-stage cervical cancer:a retrospective case-control surgico-pathological

study. Gynecol Oncol 2005, 97:727–732.CrossRef 13. Barranger E, Cortez A, Commo F, Marpeau O, Uzan S, Darai E, Calard P: Histopathological validation of the sentinel node concept in cervical cancer. Ann Oncol 2004, 15:870–874.PubMedCrossRef 14. Delpech Y, Cortez A, Coutant C, Callard P, Uzan S, Darai E, Barranger E: The sentinel node concept in endometrial cancer:histopathologic validation by serial section Oxymatrine and immunohistochemistry. Ann Oncol 2007, 18:1799–1803.PubMedCrossRef 15. Gien LT, Covens A: Quality control in sentinel node biopsy in cervical cancer. J Clin Oncol 2008,26(18):2943–2951.CrossRef 16. Daraï E, PARP inhibitor Rouzier R, Ballester M, Barranger E, Coutant C: Sentinel lymph node biopsy in gynaecological cancers:the importance of micrometastases in cervical cancer. Surg Oncol 2008,17(3):227–235.PubMedCrossRef 17. Euscher ED, Malpica A, Aykinson EN, Levenback CF, Frumovitz M, Deavers MT: Ultrastaging improves detection of metastases in sentinel lymph nodes of uterine cervix squamous cell carcinoma. Am J Surg Pathol 2008,32(9):1336–1343.PubMedCrossRef 18. Lentz SE, Muderspach LI, Felix JC, Ye W, Groshen S, Amezcua CA: Identification of micrometastases in histologically negative nodes of early-stage cervical cancer patients. Obstet Gynecol 2004,103(6):1204–1210.PubMedCrossRef 19.